JW Pharmaceutical Statistics

Total Valuation

JW Pharmaceutical has a market cap or net worth of KRW 589.10 billion. The enterprise value is 628.18 billion.

Market Cap	589.10B
Enterprise Value	628.18B

Important Dates

The next estimated earnings date is Thursday, March 13, 2025.

Earnings Date	Mar 13, 2025
Ex-Dividend Date	Dec 27, 2024

Share Statistics

JW Pharmaceutical has 24.59 million shares outstanding. The number of shares has increased by 804.72% in one year.

Current Share Class	n/a
Shares Outstanding	24.59M
Shares Change (YoY)	+804.72%
Shares Change (QoQ)	-33.05%
Owned by Insiders (%)	0.78%
Owned by Institutions (%)	11.26%
Float	14.60M

Valuation Ratios

The trailing PE ratio is 19.36 and the forward PE ratio is 6.38. JW Pharmaceutical's PEG ratio is 0.17.

PE Ratio	19.36
Forward PE	6.38
PS Ratio	1.83
PB Ratio	1.81
P/TBV Ratio	2.03
P/FCF Ratio	6.71
P/OCF Ratio	n/a
PEG Ratio	0.17

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 5.30, with an EV/FCF ratio of 7.27.

EV / Earnings	9.01
EV / Sales	0.85
EV / EBITDA	5.30
EV / EBIT	6.34
EV / FCF	7.27

Financial Position

The company has a current ratio of 1.42, with a Debt / Equity ratio of 0.44.

Current Ratio	1.42
Quick Ratio	0.93
Debt / Equity	0.44
Debt / EBITDA	1.16
Debt / FCF	1.56
Interest Coverage	9.30

Financial Efficiency

Return on equity (ROE) is 26.78% and return on invested capital (ROIC) is 13.60%.

Return on Equity (ROE)	26.78%
Return on Assets (ROA)	9.34%
Return on Capital (ROIC)	13.60%
Revenue Per Employee	692.24M
Profits Per Employee	65.53M
Employee Count	1,064
Asset Turnover	1.13
Inventory Turnover	3.51

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -30.23% in the last 52 weeks. The beta is 0.51, so JW Pharmaceutical's price volatility has been lower than the market average.

Beta (5Y)	0.51
52-Week Price Change	-30.23%
50-Day Moving Average	25,321.00
200-Day Moving Average	28,979.50
Relative Strength Index (RSI)	46.67
Average Volume (20 Days)	81,342

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, JW Pharmaceutical had revenue of KRW 736.54 billion and earned 69.72 billion in profits. Earnings per share was 1,216.27.

Revenue	736.54B
Gross Profit	334.74B
Operating Income	97.40B
Pretax Income	89.19B
Net Income	69.72B
EBITDA	116.78B
EBIT	97.40B
Earnings Per Share (EPS)	1,216.27

Full Income Statement

Balance Sheet

The company has 95.91 billion in cash and 134.99 billion in debt, giving a net cash position of -39.09 billion or -1,589.30 per share.

Cash & Cash Equivalents	95.91B
Total Debt	134.99B
Net Cash	-39.09B
Net Cash Per Share	-1,589.30
Equity (Book Value)	303.77B
Book Value Per Share	13,023.47
Working Capital	106.27B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 95.08 billion and capital expenditures -8.72 billion, giving a free cash flow of 86.36 billion.

Operating Cash Flow	95.08B
Capital Expenditures	-8.72B
Free Cash Flow	86.36B
FCF Per Share	3,511.34

Full Cash Flow Statement

Margins

Gross margin is 45.45%, with operating and profit margins of 13.22% and 9.97%.

Gross Margin	45.45%
Operating Margin	13.22%
Pretax Margin	12.11%
Profit Margin	9.97%
EBITDA Margin	15.85%
EBIT Margin	13.22%
FCF Margin	11.73%

Dividends & Yields

This stock pays an annual dividend of 392.16, which amounts to a dividend yield of 1.67%.

Dividend Per Share	392.16
Dividend Yield	1.67%
Dividend Growth (YoY)	12.06%
Years of Dividend Growth	8
Payout Ratio	13.17%
Buyback Yield	-804.72%
Shareholder Yield	-803.05%
Earnings Yield	5.16%
FCF Yield	14.91%

Dividend Details

Stock Splits

The last stock split was on December 27, 2023. It was a forward split with a ratio of 1.02.

Last Split Date	Dec 27, 2023
Split Type	Forward
Split Ratio	1.02

Scores

JW Pharmaceutical has an Altman Z-Score of 3.51.

Altman Z-Score	3.51
Piotroski F-Score	n/a